Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kenemans

Showing results (41-50 of 235) with videos related to

Pageof 24
Sort By:
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 1, 1985
Prospects and applications of monoclonal antibodies in gynecological oncologyP Kenemans, R H Verheijen, A M Leloux, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 1, 1985
Use of intermediate filament antibodies in the differential diagnosis of gynecological neoplasiaF C Ramaekers, J J Puts, P Kenemans, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1995
Quantitation of polymorphic epithelial mucin: a challenge for biochemists and immunologistsJ Hilgers, S von Mensdorff-Pouilly, A A Verstraeten, et al.
Journal of Clinical Pathology|July 1, 1995
Distribution of OV-TL 3 and MOv18 in normal and malignant ovarian tissueM R Buist, C F Molthoff, P Kenemans, et al.
Anticancer Research|September 1, 1990
Comparative in vitro binding characteristics and biodistribution in tumor-bearing athymic mice of anti-ovarian carcinoma monoclonal antibodiesO Boerman, L Massuger, K Makkink, et al.
Histopathology|June 26, 2001
Cell cycle-related proteins p21 and bcl-2: markers of differentiation in the human fallopian tubeJ M Piek, P J van Diest, R H Verheijen, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1995
Minor human antibody response to a mouse and chimeric monoclonal antibody after a single i.v. infusion in ovarian carcinoma patients: a comparison of five assaysM R Buist, P Kenemans, G J van Kamp, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 1, 1995
Confirmation of the prognostic value of the ECPI-1 score (myometrial invasion, DNA-ploidy and mean shortest nuclear axis) in FIGO stage I endometrial cancer patients with long follow-upJ.P.A. Baak, W.P. Snijders, P.J. Van Diest, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|March 1, 1994
Technical evaluation of three second generation CA 125 assaysJ M Bonfrer, A W Baan, E Jansen, et al.
Obstetrics and Gynecology|April 24, 1999
Relationship of estradiol levels to breakthrough bleeding during continuous combined hormone replacement therapyP H van de Weijer, R Barentsen, M de Vries, et al.
Pageof 24

Showing results (41-50 of 235) with videos related to

Sort By:
Pageof 24
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 1, 1985
Prospects and applications of monoclonal antibodies in gynecological oncologyP Kenemans, R H Verheijen, A M Leloux, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 1, 1985
Use of intermediate filament antibodies in the differential diagnosis of gynecological neoplasiaF C Ramaekers, J J Puts, P Kenemans, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1995
Quantitation of polymorphic epithelial mucin: a challenge for biochemists and immunologistsJ Hilgers, S von Mensdorff-Pouilly, A A Verstraeten, et al.
Journal of Clinical Pathology|July 1, 1995
Distribution of OV-TL 3 and MOv18 in normal and malignant ovarian tissueM R Buist, C F Molthoff, P Kenemans, et al.
Anticancer Research|September 1, 1990
Comparative in vitro binding characteristics and biodistribution in tumor-bearing athymic mice of anti-ovarian carcinoma monoclonal antibodiesO Boerman, L Massuger, K Makkink, et al.
Histopathology|June 26, 2001
Cell cycle-related proteins p21 and bcl-2: markers of differentiation in the human fallopian tubeJ M Piek, P J van Diest, R H Verheijen, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1995
Minor human antibody response to a mouse and chimeric monoclonal antibody after a single i.v. infusion in ovarian carcinoma patients: a comparison of five assaysM R Buist, P Kenemans, G J van Kamp, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 1, 1995
Confirmation of the prognostic value of the ECPI-1 score (myometrial invasion, DNA-ploidy and mean shortest nuclear axis) in FIGO stage I endometrial cancer patients with long follow-upJ.P.A. Baak, W.P. Snijders, P.J. Van Diest, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|March 1, 1994
Technical evaluation of three second generation CA 125 assaysJ M Bonfrer, A W Baan, E Jansen, et al.
Obstetrics and Gynecology|April 24, 1999
Relationship of estradiol levels to breakthrough bleeding during continuous combined hormone replacement therapyP H van de Weijer, R Barentsen, M de Vries, et al.
Pageof 24